Cargando…

Programmatic Impact of Implementing GeneXpert MTB/ RIF Assay for the Detection of Mycobacterium Tuberculosis in Respiratory Specimens from Pulmonary Tuberculosis Suspected Patients in Resource Limited Laboratory Settings of Eastern Nepal

BACKGROUND: In Nepal, introduction of GeneXpert MTB/RIF assay (Xpert assay) as an initial confirmation test for tuberculosis (TB) has been considered to have impact as a significant decrease in number of clinically diagnosed pulmonary tuberculosis (PTB) cases than previous years. This study aims to...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrestha, Prakash, Khanal, Hemanta, Dahal, Prasanna, Dongol, Pranita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842389/
https://www.ncbi.nlm.nih.gov/pubmed/29541267
http://dx.doi.org/10.2174/1874285801812010009
_version_ 1783304889002098688
author Shrestha, Prakash
Khanal, Hemanta
Dahal, Prasanna
Dongol, Pranita
author_facet Shrestha, Prakash
Khanal, Hemanta
Dahal, Prasanna
Dongol, Pranita
author_sort Shrestha, Prakash
collection PubMed
description BACKGROUND: In Nepal, introduction of GeneXpert MTB/RIF assay (Xpert assay) as an initial confirmation test for tuberculosis (TB) has been considered to have impact as a significant decrease in number of clinically diagnosed pulmonary tuberculosis (PTB) cases than previous years. This study aims to find out the distribution profile of suspected tuberculosis cases according to patients age, gender, treatment history and HIV status as well as to evaluate the utility of the Xpert assay over conventional acid-fast bacilli (AFB) staining method for the proper diagnosis of M. Tuberculosis in respiratory specimens from the tuberculosis (TB) suspected patient samples. METHODS: The prospective cross-sectional analytical study was conducted in National Anti-Tuberculosis Center (NATA) center- Biratnagar and Primary Healthcare Center (PHC) - Manglabare, Morang District, of eastern Nepal from January 2014 to August 2014. Laboratory investigation was done by conventional AFB staining followed by Xpert assay. RESULTS: A total of 1549 sputum samples were initially analyzed. AFB staining resulted in 1441 AFB smear negative samples and 88 AFB smear positive samples, whereas 20 samples were directly processed for Xpert assay. The male: female smear positive ratio was 2.8:1 and was higher among age groups (21-40) years. Tuberculosis among HIV patients was found 22.22%. Xpert assay demonstrates that out of 1441 smear negative AFB cases, 258 were found to have TB positive, whereas out of 88 smears positive AFB cases 12 were found to have TB negative. The sensitivity of the Xpert assay in patients classified as AFB smear positive was found 85.4% and the specificity in smear negative patients was 81%. CONCLUSION: The study concluded that implementation of Gene Xpert MTB/RIF assay is a helpful tool for early and rapid detection of tuberculosis with greater sensitivity and specificity over traditional AFB staining techniques.
format Online
Article
Text
id pubmed-5842389
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-58423892018-03-14 Programmatic Impact of Implementing GeneXpert MTB/ RIF Assay for the Detection of Mycobacterium Tuberculosis in Respiratory Specimens from Pulmonary Tuberculosis Suspected Patients in Resource Limited Laboratory Settings of Eastern Nepal Shrestha, Prakash Khanal, Hemanta Dahal, Prasanna Dongol, Pranita Open Microbiol J Microbiology BACKGROUND: In Nepal, introduction of GeneXpert MTB/RIF assay (Xpert assay) as an initial confirmation test for tuberculosis (TB) has been considered to have impact as a significant decrease in number of clinically diagnosed pulmonary tuberculosis (PTB) cases than previous years. This study aims to find out the distribution profile of suspected tuberculosis cases according to patients age, gender, treatment history and HIV status as well as to evaluate the utility of the Xpert assay over conventional acid-fast bacilli (AFB) staining method for the proper diagnosis of M. Tuberculosis in respiratory specimens from the tuberculosis (TB) suspected patient samples. METHODS: The prospective cross-sectional analytical study was conducted in National Anti-Tuberculosis Center (NATA) center- Biratnagar and Primary Healthcare Center (PHC) - Manglabare, Morang District, of eastern Nepal from January 2014 to August 2014. Laboratory investigation was done by conventional AFB staining followed by Xpert assay. RESULTS: A total of 1549 sputum samples were initially analyzed. AFB staining resulted in 1441 AFB smear negative samples and 88 AFB smear positive samples, whereas 20 samples were directly processed for Xpert assay. The male: female smear positive ratio was 2.8:1 and was higher among age groups (21-40) years. Tuberculosis among HIV patients was found 22.22%. Xpert assay demonstrates that out of 1441 smear negative AFB cases, 258 were found to have TB positive, whereas out of 88 smears positive AFB cases 12 were found to have TB negative. The sensitivity of the Xpert assay in patients classified as AFB smear positive was found 85.4% and the specificity in smear negative patients was 81%. CONCLUSION: The study concluded that implementation of Gene Xpert MTB/RIF assay is a helpful tool for early and rapid detection of tuberculosis with greater sensitivity and specificity over traditional AFB staining techniques. Bentham Open 2018-02-28 /pmc/articles/PMC5842389/ /pubmed/29541267 http://dx.doi.org/10.2174/1874285801812010009 Text en © 2018 Shrestha et al. https://creativecommons.org/licenses/by/4.0/legalcode This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Microbiology
Shrestha, Prakash
Khanal, Hemanta
Dahal, Prasanna
Dongol, Pranita
Programmatic Impact of Implementing GeneXpert MTB/ RIF Assay for the Detection of Mycobacterium Tuberculosis in Respiratory Specimens from Pulmonary Tuberculosis Suspected Patients in Resource Limited Laboratory Settings of Eastern Nepal
title Programmatic Impact of Implementing GeneXpert MTB/ RIF Assay for the Detection of Mycobacterium Tuberculosis in Respiratory Specimens from Pulmonary Tuberculosis Suspected Patients in Resource Limited Laboratory Settings of Eastern Nepal
title_full Programmatic Impact of Implementing GeneXpert MTB/ RIF Assay for the Detection of Mycobacterium Tuberculosis in Respiratory Specimens from Pulmonary Tuberculosis Suspected Patients in Resource Limited Laboratory Settings of Eastern Nepal
title_fullStr Programmatic Impact of Implementing GeneXpert MTB/ RIF Assay for the Detection of Mycobacterium Tuberculosis in Respiratory Specimens from Pulmonary Tuberculosis Suspected Patients in Resource Limited Laboratory Settings of Eastern Nepal
title_full_unstemmed Programmatic Impact of Implementing GeneXpert MTB/ RIF Assay for the Detection of Mycobacterium Tuberculosis in Respiratory Specimens from Pulmonary Tuberculosis Suspected Patients in Resource Limited Laboratory Settings of Eastern Nepal
title_short Programmatic Impact of Implementing GeneXpert MTB/ RIF Assay for the Detection of Mycobacterium Tuberculosis in Respiratory Specimens from Pulmonary Tuberculosis Suspected Patients in Resource Limited Laboratory Settings of Eastern Nepal
title_sort programmatic impact of implementing genexpert mtb/ rif assay for the detection of mycobacterium tuberculosis in respiratory specimens from pulmonary tuberculosis suspected patients in resource limited laboratory settings of eastern nepal
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842389/
https://www.ncbi.nlm.nih.gov/pubmed/29541267
http://dx.doi.org/10.2174/1874285801812010009
work_keys_str_mv AT shresthaprakash programmaticimpactofimplementinggenexpertmtbrifassayforthedetectionofmycobacteriumtuberculosisinrespiratoryspecimensfrompulmonarytuberculosissuspectedpatientsinresourcelimitedlaboratorysettingsofeasternnepal
AT khanalhemanta programmaticimpactofimplementinggenexpertmtbrifassayforthedetectionofmycobacteriumtuberculosisinrespiratoryspecimensfrompulmonarytuberculosissuspectedpatientsinresourcelimitedlaboratorysettingsofeasternnepal
AT dahalprasanna programmaticimpactofimplementinggenexpertmtbrifassayforthedetectionofmycobacteriumtuberculosisinrespiratoryspecimensfrompulmonarytuberculosissuspectedpatientsinresourcelimitedlaboratorysettingsofeasternnepal
AT dongolpranita programmaticimpactofimplementinggenexpertmtbrifassayforthedetectionofmycobacteriumtuberculosisinrespiratoryspecimensfrompulmonarytuberculosissuspectedpatientsinresourcelimitedlaboratorysettingsofeasternnepal